Literature DB >> 29935219

Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses.

Neil Romberg1, Carole Le Coz2, Salomé Glauzy3, Jean-Nicolas Schickel3, Melissa Trofa2, Brian E Nolan4, Michele Paessler5, Mina L Xu6, Michele P Lambert7, Saquib A Lakhani8, Mustafa K Khokha9, Soma Jyonouchi10, Jennifer Heimall10, Patricia Takach11, Paul J Maglione12, Jason Catanzaro13, F Ida Hsu14, Kathleen E Sullivan10, Charlotte Cunningham-Rundles12, Eric Meffre15.   

Abstract

BACKGROUND: The lack of pathogen-protective, isotype-switched antibodies in patients with common variable immunodeficiency (CVID) suggests germinal center (GC) hypoplasia, yet a subset of patients with CVID is paradoxically affected by autoantibody-mediated autoimmune cytopenias (AICs) and lymphadenopathy.
OBJECTIVE: We sought to compare the physical characteristics and immunologic output of GC responses in patients with CVID with AIC (CVID+AIC) and without AIC (CVID-AIC).
METHODS: We analyzed GC size and shape in excisional lymph node biopsy specimens from 14 patients with CVID+AIC and 4 patients with CVID-AIC. Using paired peripheral blood samples, we determined how AICs specifically affected B-and T-cell compartments and antibody responses in patients with CVID.
RESULTS: We found that patients with CVID+AIC displayed irregularly shaped hyperplastic GCs, whereas GCs were scarce and small in patients with CVID-AIC. GC hyperplasia was also evidenced by an increase in numbers of circulating follicular helper T cells, which correlated with decreased regulatory T-cell frequencies and function. In addition, patients with CVID+AIC had serum endotoxemia associated with a dearth of isotype-switched memory B cells that displayed significantly lower somatic hypermutation frequencies than their counterparts with CVID-AIC. Moreover, IgG+ B cells from patients with CVID+AIC expressed VH4-34-encoded antibodies with unmutated Ala-Val-Tyr and Asn-His-Ser motifs, which recognize both erythrocyte I/i self-antigens and commensal bacteria.
CONCLUSIONS: Patients with CVID+AIC do not contain mucosal microbiota and exhibit hyperplastic yet inefficient GC responses that favor the production of untolerized IgG+ B-cell clones that recognize both commensal bacteria and hematopoietic I/i self-antigens.
Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B-cell tolerance; Common variable immunodeficiency; autoimmune cytopenias; commensal bacteria; follicular helper T cell; germinal center responses; regulatory T cell; somatic hypermutation

Mesh:

Substances:

Year:  2018        PMID: 29935219      PMCID: PMC6400323          DOI: 10.1016/j.jaci.2018.06.012

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  24 in total

1.  Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen.

Authors:  Kathleen N Potter; Paul Hobby; Susanne Klijn; Freda K Stevenson; Brian J Sutton
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

2.  Noninfectious complications in patients with pediatric-onset common variable immunodeficiency correlated with defects in somatic hypermutation but not in class-switch recombination.

Authors:  María Belén Almejún; Bárbara Carolina Campos; Virginia Patiño; Miguel Galicchio; Marta Zelazko; Matías Oleastro; Pablo Oppezzo; Silvia Danielian
Journal:  J Allergy Clin Immunol       Date:  2016-10-03       Impact factor: 10.793

3.  Ill-defined germinal centers and severely reduced plasma cells are histological hallmarks of lymphadenopathy in patients with common variable immunodeficiency.

Authors:  Susanne Unger; Maximilian Seidl; Annette Schmitt-Graeff; Joachim Böhm; Klaudia Schrenk; Claudia Wehr; Sigune Goldacker; Ruth Dräger; Barbara C Gärtner; Paul Fisch; Martin Werner; Klaus Warnatz
Journal:  J Clin Immunol       Date:  2014-05-02       Impact factor: 8.317

4.  CVID-associated TACI mutations affect autoreactive B cell selection and activation.

Authors:  Neil Romberg; Nicolas Chamberlain; David Saadoun; Maurizio Gentile; Tuure Kinnunen; Yen Shing Ng; Manmeet Virdee; Laurence Menard; Tineke Cantaert; Henner Morbach; Rima Rachid; Natalia Martinez-Pomar; Nuria Matamoros; Raif Geha; Bodo Grimbacher; Andrea Cerutti; Charlotte Cunningham-Rundles; Eric Meffre
Journal:  J Clin Invest       Date:  2013-09-24       Impact factor: 14.808

5.  Decreased somatic hypermutation induces an impaired peripheral B cell tolerance checkpoint.

Authors:  Tineke Cantaert; Jean-Nicolas Schickel; Jason M Bannock; Yen-Shing Ng; Christopher Massad; Fabien R Delmotte; Natsuko Yamakawa; Salome Glauzy; Nicolas Chamberlain; Tuure Kinnunen; Laurence Menard; Aubert Lavoie; Jolan E Walter; Luigi D Notarangelo; Julie Bruneau; Waleed Al-Herz; Sara Sebnem Kilic; Hans D Ochs; Charlotte Cunningham-Rundles; Mirjam van der Burg; Taco W Kuijpers; Sven Kracker; Hideo Kaneko; Yujin Sekinaka; Shigeaki Nonoyama; Anne Durandy; Eric Meffre
Journal:  J Clin Invest       Date:  2016-10-04       Impact factor: 14.808

6.  Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion.

Authors:  Rimpei Morita; Nathalie Schmitt; Salah-Eddine Bentebibel; Rajaram Ranganathan; Laure Bourdery; Gerard Zurawski; Emile Foucat; Melissa Dullaers; SangKon Oh; Natalie Sabzghabaei; Elizabeth M Lavecchio; Marilynn Punaro; Virginia Pascual; Jacques Banchereau; Hideki Ueno
Journal:  Immunity       Date:  2011-01-06       Impact factor: 31.745

7.  Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity.

Authors:  Zahra Sabouri; Peter Schofield; Keisuke Horikawa; Emily Spierings; David Kipling; Katrina L Randall; David Langley; Brendan Roome; Rodrigo Vazquez-Lombardi; Romain Rouet; Jana Hermes; Tyani D Chan; Robert Brink; Deborah K Dunn-Walters; Daniel Christ; Christopher C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

8.  Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice.

Authors:  F E Johansen; M Pekna; I N Norderhaug; B Haneberg; M A Hietala; P Krajci; C Betsholtz; P Brandtzaeg
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

9.  Self-reactive VH4-34-expressing IgG B cells recognize commensal bacteria.

Authors:  Jean-Nicolas Schickel; Salomé Glauzy; Yen-Shing Ng; Nicolas Chamberlain; Christopher Massad; Isabelle Isnardi; Nathan Katz; Gulbu Uzel; Steven M Holland; Capucine Picard; Anne Puel; Jean-Laurent Casanova; Eric Meffre
Journal:  J Exp Med       Date:  2017-05-12       Impact factor: 14.307

10.  Germinal center B cells govern their own fate via antibody feedback.

Authors:  Yang Zhang; Michael Meyer-Hermann; Laura A George; Marc Thilo Figge; Mahmood Khan; Margaret Goodall; Stephen P Young; Adam Reynolds; Francesco Falciani; Ari Waisman; Clare A Notley; Michael R Ehrenstein; Marie Kosco-Vilbois; Kai-Michael Toellner
Journal:  J Exp Med       Date:  2013-02-18       Impact factor: 14.307

View more
  24 in total

Review 1.  Autoimmunity in common variable immunodeficiency.

Authors:  Shradha Agarwal; Charlotte Cunningham-Rundles
Journal:  Ann Allergy Asthma Immunol       Date:  2019-07-23       Impact factor: 6.347

Review 2.  Common variable immune deficiency: Dissection of the variable.

Authors:  Charlotte Cunningham-Rundles
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

3.  Common variable immunodeficiency-associated endotoxemia promotes early commitment to the T follicular lineage.

Authors:  Carole Le Coz; Bertram Bengsch; Caroline Khanna; Melissa Trofa; Takuya Ohtani; Brian E Nolan; Sarah E Henrickson; Michele P Lambert; Taylor Olmsted Kim; Jenny M Despotovic; Scott Feldman; Olajumoke O Fadugba; Patricia Takach; Melanie Ruffner; Soma Jyonouchi; Jennifer Heimall; Kathleen E Sullivan; E John Wherry; Neil Romberg
Journal:  J Allergy Clin Immunol       Date:  2019-08-22       Impact factor: 10.793

4.  Understanding neutropenia secondary to intrinsic or iatrogenic immune dysregulation.

Authors:  Kelly Walkovich; James A Connelly
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

5.  Disease-associated CTNNBL1 mutation impairs somatic hypermutation by decreasing nuclear AID.

Authors:  Marcel Kuhny; Lisa R Forbes; Elif Çakan; Andrea Vega-Loza; Valentyna Kostiuk; Ravi K Dinesh; Salomé Glauzy; Asbjorg Stray-Pedersen; Ashley E Pezzi; I Celine Hanson; Alexander Vargas-Hernandez; Mina LuQuing Xu; Zeynep H Coban-Akdemir; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; James R Lupski; Ivan K Chinn; David G Schatz; Jordan S Orange; Eric Meffre
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

6.  Common variable immune deficiency: case studies.

Authors:  Charlotte Cunningham-Rundles
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 7.  Beyond monogenetic rare variants: tackling the low rate of genetic diagnoses in predominantly antibody deficiency.

Authors:  Emily S J Edwards; Julian J Bosco; Samar Ojaimi; Robyn E O'Hehir; Menno C van Zelm
Journal:  Cell Mol Immunol       Date:  2020-08-17       Impact factor: 11.530

8.  Lymphoid malignancy in common variable immunodeficiency in a single-center cohort.

Authors:  Tukisa Smith; Charlotte Cunningham-Rundles
Journal:  Eur J Haematol       Date:  2021-08-06       Impact factor: 2.997

9.  TACI haploinsufficiency protects against BAFF-driven humoral autoimmunity in mice.

Authors:  Holly M Jacobs; Tanvi Arkatkar; Samuel W Du; Nicole E Scharping; Jonathan Woods; Quan-Zhen Li; Kelly L Hudkins; Charles E Alpers; David J Rawlings; Shaun W Jackson
Journal:  Eur J Immunol       Date:  2021-06-27       Impact factor: 6.688

Review 10.  Common variable immune deficiency: case studies.

Authors:  Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2019-11-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.